Pharmatech Associates, a USP company’s Post

Gain insights on our take on how we solve three main challenges in advancing cell and gene therapies to clinic. Join Qian(Sarah) Li, PhD, EMBA to learn about how #plasmid DNA serves essential roles as critical materials for cell and gene therapy applications and various key considerations including emerging methods for yield improvement, characterization and quality control. #celltherapy #genetherapy

Learn about the intricacies of manufacturing in the cell and gene therapy space in this article in SupplyChainBrain written by my colleagues Dr Paolo Siciliano, Martin Sowden, Shanton Wilcox, and Harry Ustik. They break it down into 5 key areas of opportunity for manufacturers in this space. #AutologousCommercialCellTherapy #GeneTherapy #MedicalManufacturingChallenges

📢“The goal of the Cell and Gene Therapy Access Model is to increase access to innovative cell and gene therapies for people with Medicaid by making it easier for states to pay for these therapies,” Learn More ➡️https://lnkd.in/eNrGdZe4

insights on: 🔸 Considerations for Allogenic Cell and Gene Therapy Manufacturing 🔹 Start with the Right Cells 🔸 Design Your Process with Quality 🔹 Make Your Process Scalable Thanks to Mycenax for sharing this #pharmaceutical #regulatoryaffairs #cmoinsights #manufacturing #whitepaper #cancer #biotech #gmp #outsourcing

With the Casgevy and Lyfgenia regulatory approvals breaking remarkable new ground in the treatment of sickle cell disease, SelectScience® is putting the spotlight on the opportunities and challenges in cell and gene therapy. Dive into this #AcceleratingScience feature #CGT #AAV #personalisedmedicine #genetherapies #cellandgenetherapy

Battelle’s Anthony Duong delivered his #PODD2023 talk track, "New Perspectives on Nanoparticle Platforms for Navigating Genetic Nanomedicine Through Regulatory Pathways" this week. Our experts will be in booth 4 to continue the conversation and chat about our capabilities in drug delivery. To find out more about how Battelle is advancing the field of gene therapy, read our blog “High-throughput platform propels gene editing therapy research.” https://okt.to/CfDV9y

Navigating the evolving landscape of approved cell and gene therapies poses a challenge for the drug development community. Discover insights on aligning expectations and implementing effective bioanalytical strategies in our latest eBook. For more in-depth knowledge, explore our new Cell and Gene Therapy Accelerating Science Feature: https://lnkd.in/ea6_b8_v #genetherapy, #celltherapy, and #drugdevelopment. #AAPS #BiotechInsights

Overcoming manufacturing, delivery, and affordability challenges for cell and gene therapies in the Asia-Pacific region https://lnkd.in/efNFUyFj learnings from local case studies. In this update, we share two case studies that explore how local innovators in the cell and gene therapy space in Asia-Pacific are addressing some of the major challenges for access in the region. https://lnkd.in/efNFUyFj #MarketAccess #HEOR #WeAreAvalereHealth

Interested to learn about the role of AAVs in gene therapy, how to manufacture AAVs, and moving from discovery to clinical and commercial manufacturing? Download our eBook to read about the considerations for your gene therapy manufacturing strategy!

Our review was finally published!! In it we discuss the key considerations in selecting the appropriate animal model to use in the development of novel AAV gene therapies! Check out the review, and the capabilities of the non-clinical team at Cell and Gene Therapy Catapult below. #celltherapy #cellandgenetherapy #genetherapy #genetherapies #viralvectors #nonclinical #regulatoryaffairs #nonclinicalsafety #advancedtherapies #atmp #atmps #advancedtherapies #AAV